{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:19:52Z","timestamp":1767899992274,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Technological Innovation and Demonstration of Social Undertakings Project fund of Nantong, Jiangsu, China.","award":["MSZ18206"],"award-info":[{"award-number":["MSZ18206"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with gastric cancer often exhibit poor responses to immunotherapy and experience unfavorable outcomes. This study aims to investigate the relationship between NKAIN1 levels in the tumor microenvironment and gastric carcinoma patients characteristics. Gene expression analysis, multiplex immunohistochemistry using tissue microarrays, and Quantitative Pathology Imaging System were conducted for determining the expression of NKAIN1 in gastric carcinoma tissues and association with patient outcomes. Additionally, we used the Spearman correlation method to assess the relationship between NKAIN1 protein expression in the tumor immune microenvironment and immune checkpoint markers of gastric carcinoma. Lastly, we evaluated the predictive significance of NKAIN1 presence using Cox regression models. The study findings indicated a significant increase in NKAIN1 expression in gastric carcinoma tissues compared to non-tumor stomach tissues. Moreover, a clear association between NKAIN1 expression and CTLA-4, as well as PD-L1, was identified. Importantly, the increased NKAIN1 protein expression was identified as an independent prognostic factor for adverse clinical outcomes in gastric cancer. In conclusion, this study supports NKAIN1 as a prognostic marker and promising target for immune therapy in stomach carcinoma.<\/jats:p>","DOI":"10.1038\/s41598-025-30676-0","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T01:36:22Z","timestamp":1764984982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NKAIN1 expression relates to the immune evasion and prognosis of gastric cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Lindong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinfei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"30676_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift, A. P., Wenker, T. N. & El-Serag, H. B. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat. Rev. Clin. Oncol. 20, 338\u2013349 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"30676_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"30676_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-med-081117-043436","volume":"70","author":"AE Russo","year":"2019","unstructured":"Russo, A. E. & Strong, V. E. Gastric cancer etiology and management in Asia and the West. Annu. Rev. Med. 70, 353\u2013367 (2019).","journal-title":"Annu. Rev. Med."},{"key":"30676_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41571-023-00767-w","volume":"20","author":"Y Hirata","year":"2023","unstructured":"Hirata, Y. et al. Early stage gastric adenocarcinoma: clinical and molecular landscapes. Nat. Rev. Clin. Oncol. 20, 453\u2013469 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"30676_CR5","doi-asserted-by":"publisher","first-page":"102629","DOI":"10.1016\/j.ctrv.2023.102629","volume":"120","author":"I Negura","year":"2023","unstructured":"Negura, I., Pavel-Tanasa, M. & Danciu, M. Regulatory T cells in gastric cancer: key controllers from pathogenesis to therapy. Cancer Treat. Rev. 120, 102629 (2023).","journal-title":"Cancer Treat. Rev."},{"key":"30676_CR6","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1053\/j.gastro.2023.01.018","volume":"164","author":"RJ Huang","year":"2023","unstructured":"Huang, R. J. et al. Controlling gastric cancer in a world of heterogeneous risk. Gastroenterology 164, 736\u2013751 (2023).","journal-title":"Gastroenterology"},{"key":"30676_CR7","doi-asserted-by":"publisher","first-page":"e6959","DOI":"10.1002\/cam4.6959","volume":"13","author":"Z Shaopeng","year":"2024","unstructured":"Shaopeng, Z. et al. Regulation of regulatory T cells and tumor-associated macrophages in gastric cancer tumor microenvironment. Cancer Med. 13, e6959 (2024).","journal-title":"Cancer Med."},{"key":"30676_CR8","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1002\/ctm2.1386","volume":"13","author":"J Li","year":"2023","unstructured":"Li, J. et al. Tumour-associated macrophages in gastric cancer: from function and mechanism to application. Clin. Transl Med. 13, e1386 (2023).","journal-title":"Clin. Transl Med."},{"key":"30676_CR9","doi-asserted-by":"publisher","first-page":"102175","DOI":"10.1016\/j.ctrv.2021.102175","volume":"95","author":"E Puliga","year":"2021","unstructured":"Puliga, E. et al. Microsatellite instability in gastric cancer: between lights and shadows. Cancer Treat. Rev. 95, 102175 (2021).","journal-title":"Cancer Treat. Rev."},{"key":"30676_CR10","doi-asserted-by":"publisher","first-page":"980986","DOI":"10.3389\/fimmu.2022.980986","volume":"13","author":"S Jiang","year":"2022","unstructured":"Jiang, S. et al. Identifying immune cells-related phenotype to predict immunotherapy and clinical outcome in gastric cancer. Front. Immunol. 13, 980986 (2022).","journal-title":"Front. Immunol."},{"key":"30676_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth, E. C. et al. Gastric cancer. Lancet 396, 635\u2013648 (2020).","journal-title":"Lancet"},{"key":"30676_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40169-019-0241-x","volume":"8","author":"B Agrawal","year":"2019","unstructured":"Agrawal, B. New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota. Clin. Transl Med. 8, 23 (2019).","journal-title":"Clin. Transl Med."},{"key":"30676_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2023.04.009","volume":"93","author":"Z Wang","year":"2023","unstructured":"Wang, Z., Liu, Y. & Niu, X. Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology. Semin Cancer Biol. 93, 83\u201396 (2023).","journal-title":"Semin Cancer Biol."},{"key":"30676_CR14","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1093\/hmg\/ddm167","volume":"16","author":"S Gorokhova","year":"2007","unstructured":"Gorokhova, S. et al. A novel family of transmembrane proteins interacting with beta subunits of the Na,K-ATPase. Hum. Mol. Genet. 16, 2394\u20132410 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"30676_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu, Y., Beyer, A. & Aebersold, R. On the dependency of cellular protein levels on mRNA abundance. Cell 165, 535\u2013550 (2016).","journal-title":"Cell"},{"key":"30676_CR16","doi-asserted-by":"publisher","first-page":"lqz010","DOI":"10.1093\/nargab\/lqz010","volume":"2","author":"C Wegler","year":"2020","unstructured":"Wegler, C. et al. Global variability analysis of mRNA and protein concentrations across and within human tissues. NAR Genom Bioinform. 2, lqz010 (2020).","journal-title":"NAR Genom Bioinform"},{"key":"30676_CR17","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA Pan-Cancer clinical data resource to drive High-Quality survival outcome analytics. Cell 173, 400\u2013416e411 (2018).","journal-title":"Cell"},{"key":"30676_CR18","doi-asserted-by":"publisher","first-page":"107127","DOI":"10.1016\/j.phrs.2024.107127","volume":"202","author":"Z Tang","year":"2024","unstructured":"Tang, Z. et al. CircBIRC6 facilitates the malignant progression via miR-488\/GRIN2D-mediated CAV1-autophagy signal axis in gastric cancer. Pharmacol. Res. 202, 107127 (2024).","journal-title":"Pharmacol. Res."},{"key":"30676_CR19","doi-asserted-by":"crossref","unstructured":"Lu, B. et al. Basic Transcription Factor 3 Like 4 Enhances Malignant Phenotypes through Modulating Tumor Cell Function and Immune Microenvironment in Glioma. Am J. Pathol. 194, 772\u2013784 (2024).","DOI":"10.1016\/j.ajpath.2024.01.011"},{"key":"30676_CR20","doi-asserted-by":"publisher","first-page":"113124","DOI":"10.1016\/j.colsurfb.2023.113124","volume":"222","author":"P Sun","year":"2023","unstructured":"Sun, P. et al. KRTCAP2 as an immunological and prognostic biomarker of hepatocellular carcinoma. Colloids Surf. B Biointerfaces. 222, 113124 (2023).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"30676_CR21","doi-asserted-by":"crossref","unstructured":"Abudusalam, K. et al. WSCD2 Expression: Its Relevance to Tumor-Infiltrating Immune Cells and Glioma Prognosis. Curr Med. Chem. 32, 5043\u20135052 (2025).","DOI":"10.2174\/0109298673282921240220101914"},{"key":"30676_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/carcin\/bgac074","volume":"43","author":"T Cheng","year":"2022","unstructured":"Cheng, T. et al. NDUFS4 promotes tumor progression and predicts prognosis in gastric cancer. Carcinogenesis 43, 980\u2013987 (2022).","journal-title":"Carcinogenesis"},{"key":"30676_CR23","doi-asserted-by":"publisher","first-page":"155216","DOI":"10.1016\/j.prp.2024.155216","volume":"255","author":"ZH Hakami","year":"2024","unstructured":"Hakami, Z. H. Biomarker discovery and validation for Gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers. Pathol. Res. Pract. 255, 155216 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"30676_CR24","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1158\/1078-0432.CCR-14-3334","volume":"21","author":"GH Leyten","year":"2015","unstructured":"Leyten, G. H. et al. Identification of a candidate gene panel for the early diagnosis of prostate cancer. Clin. Cancer Res. 21, 3061\u20133070 (2015).","journal-title":"Clin. Cancer Res."},{"key":"30676_CR25","doi-asserted-by":"publisher","first-page":"686809","DOI":"10.3389\/fimmu.2021.686809","volume":"12","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. Immune microenvironment and response in prostate cancer using large population cohorts. Front. Immunol. 12, 686809 (2021).","journal-title":"Front. Immunol."},{"key":"30676_CR26","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.21037\/atm-21-6237","volume":"9","author":"D Zhang","year":"2021","unstructured":"Zhang, D. et al. Development of a novel miR-3648-related gene signature as a prognostic biomarker in esophageal adenocarcinoma. Ann. Transl Med. 9, 1702 (2021).","journal-title":"Ann. Transl Med."},{"key":"30676_CR27","first-page":"853","volume":"9","author":"M Ali-Hassanzadeh","year":"2022","unstructured":"Ali-Hassanzadeh, M. et al. In Silico identification of NKAIN1 gene as a potential breast cancer associated biomarker and validation using real time PCR technique. J. Jiroft Univ. Med. Sci. 9, 853\u2013862 (2022).","journal-title":"J. Jiroft Univ. Med. Sci."},{"key":"30676_CR28","doi-asserted-by":"publisher","first-page":"e13157","DOI":"10.1111\/exsy.13157","volume":"40","author":"B Liu","year":"2023","unstructured":"Liu, B. et al. Four-gene signature based on machine learning filtration could predict prognosis of patients with breast cancer. Expert Syst. 40, e13157 (2023).","journal-title":"Expert Syst."},{"key":"30676_CR29","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/mc.23732","volume":"63","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. NKAIN1, as an oncogene, promotes the proliferation and metastasis of breast cancer, affecting its prognosis. Mol. Carcinog. 63, 1392\u20131405 (2024).","journal-title":"Mol. Carcinog."},{"key":"30676_CR30","doi-asserted-by":"crossref","unstructured":"Tang, Y. et al. Identification of five important genes to predict glioblastoma subtypes. Neuro-Oncology Advances. 3, vdab144 (2021).","DOI":"10.1093\/noajnl\/vdab144"},{"key":"30676_CR31","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","volume":"18","author":"M Egeblad","year":"2010","unstructured":"Egeblad, M., Nakasone, E. S. & Werb, Z. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell. 18, 884\u2013901 (2010).","journal-title":"Dev. Cell."},{"key":"30676_CR32","doi-asserted-by":"publisher","first-page":"e731","DOI":"10.1016\/S1470-2045(17)30607-1","volume":"18","author":"NL Syn","year":"2017","unstructured":"Syn, N. L. et al. De-novo and acquired resistance to immune checkpoint targeting. Lancet Oncol. 18, e731\u2013e741 (2017).","journal-title":"Lancet Oncol."},{"key":"30676_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.270.5238.985","volume":"270","author":"P Waterhouse","year":"1995","unstructured":"Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985\u2013988 (1995).","journal-title":"Science"},{"key":"30676_CR34","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/70932","volume":"5","author":"H Dong","year":"1999","unstructured":"Dong, H. et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5, 1365\u20131369 (1999).","journal-title":"Nat. Med."},{"key":"30676_CR35","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong, H. et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793\u2013800 (2002).","journal-title":"Nat. Med."},{"key":"30676_CR36","doi-asserted-by":"crossref","unstructured":"Kim, S. B. et al., Programmed Death Ligand 1 Regulatory Crosstalk with Ubiquitination and Deubiquitination: Implications in Cancer Immunotherapy. Int J. Mol. Sci. 25, 2939 (2024).","DOI":"10.3390\/ijms25052939"},{"key":"30676_CR37","doi-asserted-by":"crossref","unstructured":"Groeger, S. & Meyle, J. The role of programmed death receptor (PD-)1\/PD-ligand (L)1 in periodontitis and cancer. Periodontol. 2000 (2024).","DOI":"10.1111\/prd.12548"},{"key":"30676_CR38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nm863","volume":"9","author":"TJ Curiel","year":"2003","unstructured":"Curiel, T. J. et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9, 562\u2013567 (2003).","journal-title":"Nat. Med."},{"key":"30676_CR39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.drugalcdep.2013.02.006","volume":"129","author":"L Zuo","year":"2013","unstructured":"Zuo, L. et al. NKAIN1-SERINC2 is a functional, replicable and genome-wide significant risk gene region specific for alcohol dependence in subjects of European descent. Drug Alcohol Depend. 129, 254\u2013264 (2013).","journal-title":"Drug Alcohol Depend."},{"key":"30676_CR40","doi-asserted-by":"crossref","unstructured":"Bouras, E. et al., Diet and Risk of Gastric Cancer: An Umbrella Review. Nutrients 14, 1764 (2022).","DOI":"10.3390\/nu14091764"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30676-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30676-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30676-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:26:58Z","timestamp":1767882418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30676-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30676"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30676-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1012"}}